On November 28, Gelonghui reported that huaren pharmaceutical (300110.SZ) stated on the investor interaction platform that the company mainly engages in the research and development, production, and sales of peritoneal hemodialysis solutions, respiratory medications, large-volume parenteral solutions (including non-pvc soft bags, upright soft bags, plastic bottles, and glass bottles for large-volume parenteral solutions), controlled substances, active pharmaceutical ingredients, supporting pharmaceutical packaging materials, and medical instruments. The current product field has not yet involved traditional chinese medicine business.